Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by noodleyon Aug 13, 2010 9:45am
735 Views
Post# 17347974

what's up doc?

what's up doc?When will they ever learn?  On one hand....sct announces very postive move forward on tbi in today's nr.    on the other hand....doc moore pipes in about end of phase 2 stroke bla bla bla.  don't you almost get the sense the thing was written by two people?  Or the sense that the doc is justifying/reminding us he's still part of this?   i was actually relieved that he didn't go into more detail on placebo and failure for the umpteenth time.  I guess for anyone wanting to buy into this ride at a very low price....doc moore is a friend.  Had he kept his trap shut....lord knows where the sp might be....10 maybe .12?   This guy needs to quietly set things up with fda ....then retire at the end of the year. 
Bullboard Posts